Business
India Pharmaceutical Exports: India’s pharma exports rise 5.6% to $28.29 billion till Feb in FY26; sector seen doubling to $130 billion by 2030 – The Times of India
India’s pharmaceutical exports remained on a growth track in the last financial year despite global headwinds, crossing $28 billion during April–February FY26, while industry leaders said the sector is on course to nearly double in size to $130 billion by 2030.Speaking at the inaugural session of the ‘Chintan Shivir: Scaling Up Pharma Exports’ on Saturday, K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), said pharma exports stood at $28.29 billion in April–February FY26, marking a 5.6 per cent increase over the same period of FY25.“Despite global challenges, pharmaceutical exports have been among the few sectors to maintain growth momentum. Exports during April–February FY26 stood at $28.29 billion, reflecting a growth of 5.6 per cent compared to the same period in FY25, led by formulations, biologicals, vaccines and AYUSH products,” Bhanu said.Bhanu said the Indian pharmaceutical sector, currently valued at around $60 billion, is projected to grow to $130 billion by 2030. He added that pharma exports reached $30.47 billion in FY2024–25, recording a 9.4 per cent year-on-year growth despite global pricing pressures and trade volatility.He said Pharmexcil is targeting $65 billion in exports by 2030, backed by policy prioritisation, diversification beyond traditional markets, higher FDI inflows and faster regulatory clearances.India currently ranks third globally in pharmaceutical production by volume, with shipments reaching more than 200 markets, he said. Bhanu also noted that over 60 per cent of India’s pharma exports go to highly regulated markets, highlighting the sector’s quality and compliance standards.According to him, the United States accounts for 34 per cent of India’s pharmaceutical exports, followed by Europe at 19 per cent.Commerce secretary Rajesh Agrawal said the sector is likely to stay on a positive trajectory even if export targets prove difficult to meet in dollar terms, given the weakening rupee.“The target we have set appears difficult to meet, but we will remain on a positive trajectory,” Agrawal said.He added that regardless of whether targets are achieved in dollar terms, export growth would still reflect positively in rupee terms as the Indian currency continues to weaken against the US dollar.Pharmexcil chairman Namit Joshi said India is likely to end the current financial year at levels comparable to FY25, while flagging the effect of front-loaded US buying.“That is why we expect to end up close to last year’s performance, with some growth coming from that,” Joshi said.Joshi said tariff-related issues in 2025 led to higher procurement of medicines worth $1.6 billion in the US, above normal levels, and that this is expected to influence FY26 numbers.
US tariff backdrop may shape future outlook
While the immediate focus remains on export resilience, the external environment—especially in the US, India’s biggest pharma market—could become a key variable going forward.The US has announced a fresh tariff framework targeting patented drugs and certain high-value pharmaceutical ingredients manufactured outside America, with duties of up to 100 per cent set to take effect between August and September 2026 after a transition period.However, the near-term hit to India may be limited because generic medicines are currently exempt, and about 90 per cent of India’s pharmaceutical exports to the US are generics, as per a GTRI report. The report said India exported $9.7 billion worth of pharmaceuticals to the US in 2025, accounting for 38 per cent of its global pharma exports of $25.8 billion.
Business
India’s fuel demand growth may slow sharply in H2 2026 amid price hikes, austerity push: Report
India’s transportation fuel demand growth is expected to slow sharply in the second half of 2026 as higher fuel prices, government-led conservation measures and a weakening rupee weigh on mobility and consumption trends, according to a report.The report by Kpler’s lead analyst (modelling), Elif Binici, revised down India’s 2026 refined products demand growth forecast by around 77,000 barrels per day (kbd), or 39 per cent, to nearly 78 kbd from an earlier estimate of 128 kbd.As per news agency PTI, the downgrade reflects weaker expected growth in petrol and diesel demand due to elevated fuel costs, softer mobility trends and official efforts to conserve fuel amid the ongoing West Asia crisis.Petrol and diesel prices have been increased by around Rs 5 per litre in three instalments since May 15, after oil marketing companies passed on part of the burden of soaring global crude oil prices to consumers.
Petrol demand faces steepest downside risk
The report said petrol demand is likely to see the sharpest slowdown, with projected growth revised down by 25 kbd, from 63 kbd to 38 kbd.Petrol consumption is now estimated at 1,010 kbd, compared to the earlier estimate of 1,035 kbd.According to the report, weaker commuting activity, slower discretionary travel and government fuel-saving campaigns are expected to curb fuel consumption.Annual diesel demand growth was also cut by around 20 kbd, while jet fuel demand growth was nearly halved to about 6 kbd from 11 kbd earlier due to expectations of reduced air travel and tighter spending patterns.“The revisions primarily reflect weaker expected growth in gasoline and diesel demand as higher costs, weaker mobility trends, and recent government-led fuel conservation efforts increasingly feed into domestic transportation activity,” the report said, as quoted by PTI.
Rupee weakness, crude surge add pressure
The report noted that India’s macroeconomic environment has deteriorated since the escalation of the US-Iran conflict, with rising crude import costs, refinery expenses and rupee depreciation increasing inflationary pressure.The rupee has weakened by around 6 per cent since the conflict began and nearly 10 per cent over the past year. Foreign exchange reserves have also reportedly declined by about 4.3 per cent since late February as authorities attempted to stabilise the currency and contain imported inflation.The report said the current average petrol price of around Rs 103 per litre remains well below the estimated breakeven level of nearly Rs 125 per litre.Diesel prices near Rs 94 per litre are also below the estimated breakeven range of Rs 115-120 per litre.Before the recent price revisions, state-run fuel retailers were reportedly losing nearly Rs 1,000 crore daily because rising crude procurement costs and currency weakness outpaced retail fuel prices.“The key issue is the inability of state-run retailers to pass through rising import costs quickly enough to restore profitability,” the report said.
Russian crude continues to support supply security
The report added that India’s dependence on discounted Russian crude imports, estimated at around 1.9-2 million barrels per day, continues to provide stability to the domestic fuel market amid geopolitical uncertainty in West Asia.Policymakers now appear to be prioritising macroeconomic stability, inflation management, foreign exchange preservation and fuel supply security over near-term fuel demand growth.The report warned that unless crude prices ease significantly, the rupee stabilises or additional fiscal support measures are introduced, further fuel price hikes and stricter fuel-conservation measures may become difficult to avoid.
Business
Market recap: 6 of top-10 most-valued firms add Rs 74,111 crore; Reliance biggest winner
The combined market valuation of six of India’s top-10 most valued companies rose by Rs 74,111.57 crore last week, with Reliance Industries emerging as the biggest gainer. The rally came during a volatile trading week in which the BSE Sensex advanced 177.36 points, or 0.23%.According to news agency ANI, Reliance Industries added Rs 24,696.89 crore to its valuation, taking its total market capitalisation to Rs 18,33,117.70 crore.Tata Consultancy Services saw its valuation jump by Rs 19,338.68 crore to Rs 8,38,401.33 crore, while ICICI Bank added Rs 14,515.93 crore to reach a market capitalisation of Rs 9,06,901.32 crore.The valuation of Life Insurance Corporation of India climbed Rs 9,076.37 crore to Rs 5,14,443.69 crore.Meanwhile, Bajaj Finance gained Rs 3,797.83 crore, taking its valuation to Rs 5,70,515.57 crore, while Larsen & Toubro added Rs 2,685.87 crore to Rs 5,40,228.21 crore.
Airtel, HUL among laggards
On the losing side, Bharti Airtel witnessed the sharpest erosion in market value, losing Rs 20,229.67 crore to settle at Rs 11,40,295.49 crore.The market valuation of Hindustan Unilever declined by Rs 16,212.18 crore to Rs 5,17,380 crore, while State Bank of India lost Rs 12,784.4 crore in valuation to Rs 8,76,077.92 crore.HDFC Bank also saw its market capitalisation dip by Rs 2,094.35 crore to Rs 11,79,974.90 crore.Reliance Industries retained its position as India’s most valued company, followed by HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, TCS, Bajaj Finance, Larsen & Toubro, Hindustan Unilever and LIC.
Markets end volatile week with modest gains
Ajit Mishra, SVP, research at Religare Broking Ltd, said markets ended the week with marginal gains amid a “highly volatile and range-bound trading environment”.“Benchmark indices witnessed sharp intraday swings throughout the week, driven by persistent rupee weakness, mixed global cues, sectoral rotation, and continued uncertainty around inflation and interest rates,” he said, as quoted by ANI.Benchmark indices recovered on Friday, with the Sensex closing 231.99 points higher at 75,415.35 and the NSE Nifty rising 64.60 points to settle at 23,719.30.Analysts cited optimism surrounding possible progress in US-Iran peace negotiations and easing Middle East tensions as factors supporting market sentiment.Vinod Nair, head of research at Geojit Investments, was quoted by news agency PTI as saying that domestic markets traded with a “mild positive bias” due to buying at lower levels and constructive global cues.“Globally, the AI investment theme remained the primary driver, while domestically, financial stocks led the gains,” he said.Brent crude prices climbed 2.3% to $104.7 per barrel, while foreign institutional investors (FIIs) sold equities worth Rs 1,891.21 crore in the previous session.
Business
Why essentials like eggs, bread and milk cost so much more now
Six supermarket brand eggs cost £1 in 2022. How much are they now, why have they gone up, and is anyone profiteering?
Source link
-
Entertainment1 week agoWhere Pete Davidson, Elsie Hewitt stand after breakup: Details revealed
-
Politics1 week agoRising diesel costs from Iran war strain US school budgets
-
Entertainment1 week agoDrake drops highly anticipated "Iceman" album, plus two surprise albums
-
Tech1 week agoGreg Brockman Officially Takes Control of OpenAI’s Products in Latest Shakeup
-
Tech1 week agoWhy Is Your Grill So Dumb? The Best Grills Set Temp Like an Oven
-
Tech1 week agoThis Solar-Powered Smart Sprinkler Keeps My Lawn Watered Without Any Power Cables
-
Fashion1 week agoRMG trade bodies seek policy support from Bangladesh PM
-
Business1 week agoOil price gains and Westminster worry sink stocks
